Pages that link to "Q44324883"
Jump to navigation
Jump to search
The following pages link to Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis (Q44324883):
Displaying 50 items.
- Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry (Q22305306) (← links)
- Home versus hospital intravenous antibiotic therapy for cystic fibrosis (Q24187116) (← links)
- Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis (Q24187987) (← links)
- Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis (Q24200822) (← links)
- Home versus hospital intravenous antibiotic therapy for cystic fibrosis (Q24201353) (← links)
- Interventions for the eradication of methicillin resistant Staphylococcus aureus in people with cystic fibrosis (Q24203763) (← links)
- Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseases (Q26823282) (← links)
- Clinical applications of pulmonary delivery of antibiotics (Q26996053) (← links)
- Cystic fibrosis chronic rhinosinusitis: a comprehensive review (Q27003313) (← links)
- MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis (Q28596703) (← links)
- Background and Epidemiology (Q30248742) (← links)
- Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection (Q30419079) (← links)
- Influenza vaccination in children with cystic fibrosis. (Q30429062) (← links)
- Cost of care for cystic fibrosis: an investigation of cost determinants using national registry data. (Q30841523) (← links)
- Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis (Q33594673) (← links)
- Update in cystic fibrosis 2012. (Q33738510) (← links)
- Multicenter Observational Study on Factors and Outcomes Associated with Various Methicillin-Resistant Staphylococcus aureus Types in Children with Cystic Fibrosis (Q33783497) (← links)
- Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections (Q33786154) (← links)
- Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis--the PMEP trial: study protocol for a randomized controlled trial (Q33797709) (← links)
- Cystic fibrosis: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases (Q33807353) (← links)
- D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection (Q33809988) (← links)
- Lung Microbiota and Its Impact on the Mucosal Immune Phenotype. (Q33833225) (← links)
- Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Pulmonary Exacerbation in a Pediatric Cystic Fibrosis Patient (Q33886807) (← links)
- Fosfomycin/tobramycin for inhalation in patients with cystic fibrosis with pseudomonas airway infection (Q34233774) (← links)
- Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. (Q34348146) (← links)
- Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. (Q34478074) (← links)
- Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis (Q34491552) (← links)
- Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio (Q34737606) (← links)
- Longitudinal association between medication adherence and lung health in people with cystic fibrosis. (Q35042866) (← links)
- Pharmacokinetics of Intravenous and Oral Linezolid in Adults with Cystic Fibrosis (Q35065732) (← links)
- Infections in patients with cystic fibrosis: diagnostic microbiology update (Q35173126) (← links)
- Antibiotic management of methicillin-resistant Staphylococcus aureus--associated acute pulmonary exacerbations in cystic fibrosis (Q35542062) (← links)
- Reduced bacterial colony count of anaerobic bacteria is associated with a worsening in lung clearance index and inflammation in cystic fibrosis. (Q35628853) (← links)
- Gender differences in outcomes of patients with cystic fibrosis (Q35641585) (← links)
- Clinical outcomes associated with Staphylococcus aureus and Pseudomonas aeruginosa airway infections in adult cystic fibrosis patients (Q35669548) (← links)
- Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis. (Q35864774) (← links)
- The Microbiome in Cystic Fibrosis (Q35917770) (← links)
- Outcomes and Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Differs by Staphylococcal Cassette Chromosome mec (SCCmec) Type in Children With Cystic Fibrosis (Q36009637) (← links)
- Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study. (Q36015095) (← links)
- The Dynamics of Disease Progression in Cystic Fibrosis (Q36036190) (← links)
- Throat Swabs and Sputum Culture as Predictors of P. aeruginosa or S. aureus Lung Colonization in Adult Cystic Fibrosis Patients (Q36155055) (← links)
- Cystic fibrosis: a mucosal immunodeficiency syndrome. (Q36623329) (← links)
- Emergence of cfr-Mediated Linezolid Resistance in a Methicillin-Resistant Staphylococcus aureus Epidemic Clone Isolated from Patients with Cystic Fibrosis. (Q36644711) (← links)
- Clinical Significance and Pathogenesis of Staphylococcal Small Colony Variants in Persistent Infections. (Q36675223) (← links)
- Children and young adults with CF in the USA have better lung function compared with the UK. (Q36818364) (← links)
- Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection (Q37129932) (← links)
- Update on Epidemiology and Treatment of MRSA Infections in Children (Q37158339) (← links)
- Antibiotic and anti-inflammatory therapies for cystic fibrosis (Q37201467) (← links)
- Prevention and treatment of Staphylococcus aureus biofilms (Q37482155) (← links)
- Influenza vaccination in children at high risk of respiratory disease (Q37668402) (← links)